Two Sigma Advisers’s OmniAb OABI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-197,530
Closed -$365K 1462
2025
Q4
$365K Buy
197,530
+71,500
+57% +$124K ﹤0.01% 1906
2025
Q3
$202K Buy
126,030
+18,100
+17% +$33.1K ﹤0.01% 2134
2025
Q2
$188K Buy
+107,930
New +$181K ﹤0.01% 2131
2023
Q4
Sell
-11,050
Closed -$57.4K 2601
2023
Q3
$57.4K Sell
11,050
-4,000
-27% -$21.3K ﹤0.01% 2266
2023
Q2
$75.7K Buy
15,050
+2,200
+17% +$8.92K ﹤0.01% 2238
2023
Q1
$47.3K Buy
12,850
+1,100
+9% +$4.15K ﹤0.01% 2454
2022
Q4
$42.3K Buy
+11,750
New +$61.7K ﹤0.01% 2377

Other funds holding OABI

Two Sigma Advisers's OABI Position: Q1 2026 in Review

Two Sigma Advisers sold out of OmniAb (OABI) in Q1 2026, closing a stake of 197,530 shares — an estimated $365K sold.

Two Sigma Advisers first reported a position in OABI in Q4 2022 and held it in 7 quarters. The position peaked at $365K in Q4 2025. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Two Sigma Advisers reported no remaining OmniAb position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 197,530 OmniAb shares in Q1 2026, an estimated $365K.
  • Two Sigma Advisers first reported a position in OmniAb in Q4 2022 and held it in 7 quarters.
  • Two Sigma Advisers's OmniAb position peaked at $365K in Q4 2025.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.